High levels of P-eEF2 were reported in a mouse model of Alzheimer’s disease [47] and in brain samples of patients affected by Alzheimer’s disease [47, 53] as a consequence of the pathological activation of AMPK followed by the activation of eEF2K [51]. This evidence concerns the gene EEF2K and early-onset autosomal dominant Alzheimer disease.